Dv-Pharm Limited
07034936
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 14/11/2025
Due 28/11/2026
Industry
Officers
director · Since 28/10/2009
PHARMACIST
BRITISH · UNITED KINGDOM · Age 70
Also on 1 other board
director · Since 10/04/2016
DIRECTOR
BRITISH · UNITED KINGDOM · Age 68
Also on 1 other board
Persons with Significant Control
Mr Anish Dipak Mehta
British · England · Age 42
Devonshire House, 582 Honeypot Lane, Stanmore, HA7 1JS
Notified 14/11/2019
Former PSCs
Mr Dipak Vanechand Mehta
Ceased 14/11/2019
Mrs Nileema Dipak Mehta
Ceased 14/11/2019
CompanyRankvs 400+ SIC 47730 peers83
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£523k
Balance sheet strength
Cash
£198k
Cash in the bank
Net Current Assets
£495k
Working capital
Current Assets
£680k
Current Liabilities
£186k
Fixed Assets
£30k
Debtors
£396k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 3.67 | +£28 |
| 2024 | 3.43 | -£38k |
| 2023 | 5.65 | — |
Derived from filed accounts. Not audited figures.